Filing Details

Accession Number:
0001415889-24-024003
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-26 18:15:52
Reporting Period:
2024-09-24
Accepted Time:
2024-09-26 18:15:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1681087 Tectonic Therapeutic Inc. TECX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055624 A Timothy Springer C/O Tectonic Therapeutic, Inc.
490 Arsenal Way, Suite 210
Watertown MA 02472
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-09-24 1,240,893 $0.00 310,223 No 4 J Indirect By LLC
Common Stock Acquisiton 2024-09-24 1,054,759 $0.00 3,746,764 No 4 J Direct
Common Stock Acquisiton 2024-09-24 186,134 $0.00 186,134 No 4 J Indirect By Spouse
Common Stock Acquisiton 2024-09-26 24,531 $28.16 3,771,295 No 4 P Direct
Common Stock Acquisiton 2024-09-26 18,999 $29.13 3,790,294 No 4 P Direct
Common Stock Acquisiton 2024-09-26 4,070 $30.10 3,794,364 No 4 P Direct
Common Stock Acquisiton 2024-09-26 2,400 $30.87 3,796,764 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect By LLC
No 4 J Direct
No 4 J Indirect By Spouse
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents a distribution in kind, for no additional consideration, by TAS Partners, LLC ("TAS") to the Reporting Person and his spouse.
  2. These shares are held by TAS. The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  3. Represents the acquisition of the shares from TAS, as more specifically described in Footnote (1) herein.
  4. The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $27.68 to $28.66 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $28.69 to $29.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $29.75 to $30.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $30.80 to $30.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.